A Deep Dive into MASH: Exploring the Role of Metabolic Dysfunction in Disease Pathophysiology

Description

This presentation will examine MASH (metabolic dysfunction-associated steatohepatitis) and the role of cardiometabolic dysfunction in disease development and progression. We will also discuss current AASLD guidelines regarding screening and management of patients at high-risk for advanced disease.

Industry Supporter: Novo Nordisk, Inc.